The Amerlex FT4 radioimmunoassay has been assessed. It is simple, quick, and precise.
In normal human subjects approximately 99·97 % thyroxine (T4) is bound to thyroxine-binding globulin (TBG), thyroxine-binding prealbumin, and albumin. Total thyroxine (tT4) and the binding protein concentrations can fluctuate independently so that any given free thyroxine (FT4) level can arise from a spectrum of different combinations of protein and T4 levels. For this reason the theoretically ideal indicator of thyroid status is the assay of FT4. Over the last two decades the only methods available were time-consuming and suitable only for the research laboratory. Recently, however, a number of kits for the assay 01 FT4 have been produced-and we have assessed one of these (the Immo Phase FT4) in detail," Shortly after our previous work had been completed a new kit became available, the Amerlex FT4, based on a different principle. This is essentially a classical radioimmunoassay (RIA) which uses a labelled analogue of T4, which although not binding to serum proteins, binds to the antiserum in the same way as does T4. The manufacturers claim that this methodology 'has a negligible effect on the T4/binding protein equilibrium' in contrast to coated tube methods, membrane separation methods, and kinetic rate reaction methods and so 'provides a true FT4 assay'.
In view of this claim, and because we had not found the Immo Phase FT4 assay (a kinetic rate reaction method) to be superior to the free thyroxine index (FTI) as we had expected," we have reassayed ·Present address: Nuclear Medicine Laboratory, St Vincent's Hospital, Elm Park, Dublin 4, Eire samples from our previous work using the Amerlex kit and assessed its clinical discrimination as a diagnostic test of thyroid function.
Our previous work with the Immo Phase kit failed to demonstrate any significant difference in FT4 values in the second and third trimesters of pregnancy.s In contrast, the values quoted for the Amerlex FT4 in pregnancy by the manufacturer show decreasing values throughout pregnancy. We therefore decided to investigate FT4 values in pregnancy using kits based on widely differing methodologies.
Subjects and methods

AMERLEX FT4 ASSESSMENT
The samples used in assessing the Amerlex FT4 kit were those from our previous work; they had been refrozen and stored at -20°e.
In some cases there was insufficient sample for a repeat assay. The seven groups of subjects were: hyperthyroid (n= 11), hypothyroid (n=6), pregnant (n=23), contraceptive pill users (n=20), acutely ill patients (n= 38), elderly (n= 19) and euthyroid (n=48). Further details are given in our previous paper. 2 FT4 was assayed using the Amerlex kit (Amersham International, Amersham, Bucks). The principle of this kit is illustrated in Figure 1 . When the 125 1 T4analogue is mixed with a serum sample and a specific high-affinity T4-antibody, an equilibrium is established in which the FT4 and the labelled T4 derivative compete for a limited number of binding sites 374 on the antibody. The antibody is bound to polymer particles of uniform diameter, so that after equilibrium at 37°C the bound fraction can easily be separated by centrifugation. After the tubes have been decanted and drained they are counted and the results are calculated using a conventional RIA procedure. are excluded from interaction with antibody. At the end of the incubation period, a solution of polyethylenimine is added to all the tubes to wash the unbound labelled T4 from the capsules and to facilitate the formation of a stable centrifugal pellet.
The Lisophase FT4 kit is a modification of the earlier Lepetit method.s FT4 is adsorbed onto a resin column (Sephadex LH-20). The protein fraction is eluted by washing with buffer, and the adsorbed T4 is eluted onto another chromatographic column (the Lisophase column). After incubating with 1251_T4 and antiserum at room temperature, the unbound T4 is eluted by washing with buffer, while the T4-antibody complex remains bound to the resin column by affinity chromatography. (The column contains Sepharose gel to which a second antibody is covalently linked.) The columns are counted and results are calculated as in any other RIA.
The free thyroxine index (FT!) was calculated as the ratio of the total thyroxine as given by the Immo Phase kit (which measures both total and free thyroxine) and the T3-uptake measured by Thyopac 3 (Amersham International).
Samples were also obtained at 16 weeks and 35 weeks gestation during six individual pregnancies (age range of women 26-39 years). FT4 was assayed in these 12 samples by the Immo Phase and the Amerlex kits.
FT4 IN PREGNANCY
Samples were obtained from 20 euthyroid nonpregnant women (age range 18-52 years) and 20 euthyroid women near the end of pregnancy (age range 15-39 years; gestation range 30-39 weeks). FT4 was measured in these 40 samples by five different kits. Specimens were assayed in one run, alternating the normal and pregnant samples in order to eliminate any effect of potential assay drift.
The other kits used were the GammaCoat (Clinical Assays, Thetford, Norfolk) Liquisol (Damon Diagnostics, as distributed by CIS, Finchley, London), and the Lisophase (Lepetit and Dow Diagnostic Products, Uniscience, Cambridge).
The GammaCoat FT4 assay is an RIA which is performed entirely in the antibody-coated tubes. In the first (brief) incubation with diluted serum, FT4 binds to the tubes. The liquid is then removed and the remaining antibody binding sites are saturated in the second incubation with 125 1 T4.
The Liquisol kit relies on thin-membraned nylon microcapsules, which contain an antibody presaturated with 1251_T4.3 Serum is incubated with a suspension of microcapsules at 37°. Labelled and unlabelled FT4 pass through the membrane and equilibrate, whereas the protein-bound T4 molecules
Results
FT4 VALUES ON REFROZEN SAMPLES
Twenty samples, spanning a wide range of FT4 values (7·7-25·2 pmol/l), were assayed after a single freezing (mean±SD=15·02±4·15) and after refreezing four times (mean±SD=14·76+5·50). These figures show no significant difference at the 5% level and so justify the use of re-frozen samples in the assessment of the Amerlex FT4 kit. Table 1 gives figures for the within-assay and between-assay precision for the Amerlex FT4 kit. The Amerlex FT4 results in the seven patient groups are shown in Figure 2 . This may be compared with Fig. 1 of our previous paper," The mean FT4 values for each group are given in Table 2 , which also gives the number of values falling outside the euthyroid reference range expressed both as a number and as a percentage.
AMERLEX FT4 ASSESSMENT
FT4 IN PREGNANCY
Inter-kit comparison. Figure 2 shows that over half the Amerlex FT4 values in the second and third trimesters of pregnancy lie below the lower limit of Table 4 shows that in each pregnancy the Amerlex FT4 was lower at 35 weeks than at 16 weeks. The Immo Phase results were either slightly higher or slightly lower, but the small differences are insignificant when compared with intra-assay variation.
Tuttlebee
Discussion
AMERLEX FT4 ASSESSMENT
Quality control carried out on the kit gave intraassay and inter-assay coefficients of variation of less than 8 %, a satisfactory performance for a routine RIA. Other workers have achieved comparable precision.s " The normal range found in this study was 12·3-28·7 pmol/l, slightly higher than quoted in the literature accompanying the assay of 8· 8~23· 0 pmol/I, but very similar to the range we established on 62 subjects including these 47, for the Immo Phase kit, of 14·0--26·4 pmol/l.! The clinical discrimination was broadly similar to that of the Immo Phase FT4 kit, except in the case of acute illness and pregnancy, where over half of the values fell below our reference range.
There has been much discussion in the literature about thyroid function in 'non-thyroidal illness' (NTI). In these subjects several workers have found FT4 levels, measured by equilibrium dialysis, to be either normal or elevated." 8 We have shown that Immo Phase FT4 on this group of patients are either normal or low. 2 Our results with the Amerlex kit are similar, but the effect is more pronounced (57% of Amerlex values are low, compared with 29 % of Immo Phase values).
Recently, Kaptein et al. 9 have shown that only three out of eight methods that they used to estimate FT4 concentrations gave normal values in NT!. They believe that these methods are likely to be correct in view of the normal T4-disposal rates generally found in this group of patients, and speculate that the T4-binding inhibitor in NTI, partially elucidated by Chopra et al., may be appropriately reflected in some FT4 methods but not in others.
Bearing these limitations in mind, the Amerlex FT4 RIA is precise, technically simple, and straightforward, is comparable in cost to the FTI, and can be completed within 2 hours.
FT4 IN PREGNANCY
The Amerlex results on pregnant women shown in Fig. 1 parallel those obtained by Mahlstedt et al. 6 using this kit. They found that half the FT4 values in the third trimester of pregnancy fell below the euthyroid reference range.
The results of our further study of free thyroxine assays on pregnant subjects indicate that current FT4 RIA kits fall into two groups with respect to values obtained during pregnancy: those that show no significant difference in values throughout pregnancy (the Immo Phase and the Liquisol kits) and those that give significantly lower values as pregnancy progresses (Amerlex, GammaCoat, and Lisophase). We have shown, using one kit from each group, that this is also true not only of the overall trend (Table 4 ) but also of individual pregnancies.
Our results differ from those of Boss et al. t o who used Immo Phase kit. They found slightly decreasing FT4 values throughout pregnancy, whereas our results show no significant differences between values in the second and third trimesters.s nor between samples obtained from pregnant and nonpregnant subjects. However, the differences are small and may merely reflect a change in kit reagents, for example, a change of antibody.
What is the 'true' FT4 in pregnancy? Earlier equilibrium dialysis methods gave some conflicting answers. Anderson, for example," reported significantly lower values in pregnancy; others, for example, Souma et alP, found that free thyroxine remained unchanged in pregnancy and could be compared with 'nonpregnant' values. A straightforward view of the free thyroxine hypothesis would suggest that FT4 concentrations should remain unchanged throughout pregnancy while the total T4 concentrations should increase due to the parallel rise in TBG. It is of note that FT4 concentrations in patients taking oral contraceptives, where there are also increased oestrogen and TBG levels (in this work a mean of 31· 3 Il-g/ml compared with 37·3 Il-g/rnl for third-trimester pregnancy samples as measured by the CIS kit), are not significantly different from values in euthyroid patients whether measured by the Immo Phase kit 2 or the Amerlex kit. This might indicate that the decrease in FT4 in pregnancy shown by some procedures is a methodological artefact. On the other hand, Ekins 12 has proposed a physiological mechanism to account for lowered FT4 values in pregnancy from a consideration of thyroxine transport across the capillary membrane of the target tissues. Which of these approaches is correct remains to be seen.
The Amerlex FT4 results are as good as those of Immo Phase and FTI in hyperthyroid, hypothyroid, and elderly patients but give significantly lower values in acute illness and pregnancy. We have been unable to study the effects of the method on the T4/binding protein equilibrium, but doubt must be entertained as to whether any method can claim to give a 'true' FT4 value at this stage in the development of FT4 radioimmunoassays. Variations such as the amount and affinity of the T4-specific antibody, the incubation temperature, buffers, pH, ionic composition, and separation procedures probably contribute to the differences between FT4 values in pregnancy and acute illness, as assessed by different techniques. Much more work is required into the theory of free thyroid hormones and into the methodologies of the various assays available.
I should like to thank all the manufacturers mentioned for their generous gifts of FT4 kits without which this work would not have been possible.
